Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001288123-10-000021)

Filing Details

Accession Number:: 0001288123-10-000021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-18 13:00:00
Reporting Period:: 2010-03-16

Filing Date:: 2010-03-18
Accepted Time:: 2010-03-18 15:22:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Antigenics Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1437152	Karen Valentine	C/O Antigenics Inc. 3 Forbes Rd Lexington MA 02421	Vp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-16	29,039	$0.76	51,491	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The reported transaction was executed at sales prices ranging from $0.7510 to $0.7714. The reporting person undertakes to provide, upon the request by the SEC staff, Antigenics Inc. or any stockholder of Antigenics Inc., the full information regarding the number of shares sold at each separate price.